EPHX2 and Obesity: This is consistent with preclinical models of obesity 102, 103, suggesting a decreased CYP450 and increased sEH expression, and the overall increased EETs in subjects with coronary artery disease may be a compensatory response to the presence of advanced cardiovascular disease.